Malvern Panalytical

Malvern Panalytical’s scientific measurement instruments are used by the pharmaceutical industry to confirm the identity, activity, molecular conformation, morphological properties, solid form and stability of APIs and excipients. There are many applications in drug delivery.

Head Office
Malvern Panalytical Ltd
Enigma Business Park
Grovewood Road
Malvern
Worcestershire
WR14 1XZ
United Kingdom

Phone / Contact

T: +44 1684 892 456
F: +44 1684 892 789

Articles by Malvern Panalytical

SPRAYTEC LASER DIFFRACTION: ROBUST, REPRODUCIBLE DROPLET SIZE DATA

Anne Virden discusses the benefits and applications of Malvern Panalytical's Spraytec laser diffraction system for the measurement of spray particles and droplets.

SOLVING COMPLEX FORMULATION & DELIVERY CHALLENGES FOR INTRANASAL DRUGS

Paul Kippax discusses the analytical techniques used for in vitro characterisation of nasal sprays, and how their use can accelerate and de-risk both innovator and generic nasal drug development.

PHYSICOCHEMICAL BIOEQUIVALENCE IN OPHTHALMIC MICROEMULSIONS

Here, Paul Kippax describes the methods by which bioequivalence can be established for ophthalmic microemulsions by in vitro testing, saving the need for costly clinical trials.

Déborah Le Pennec

GENERIC NEBULISER BIOEQUIVALENCE: OPTIMISING ANALYTICAL STRATEGIES

Déborah Le Pennec, Laurent Vecellio, Paul Kippax and Stephane Rouquette look at the optimal application of laser diffraction and automated imaging within the context of the US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser.

INVESTIGATING THE DE-AGGLOMERATION PROFILES OF DPI FORMULATIONS

Paul Kippax from Malvern Instruments, Srinivas Ravindra Babu Behara, David Morton, Ian Larson and Peter Stewart from Monash University describe the use of laser diffraction to analyse dry powder behaviour.

Dr Deborah Huck-Jones

SCOPING THE DESIGN SPACE FOR GENERIC NASAL SPRAYS

Deborah Huck-Jones and Paul Kippax discuss analytical methods that can be helpful for demonstrating bioequivalence in the development of generic nasal sprays.

Top